RECURRENT PERICARDITIS
Clinical trials for RECURRENT PERICARDITIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PERICARDITIS trials appear
Sign up with your email to follow new studies for RECURRENT PERICARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug switch aims to simplify treatment for recurring heart inflammation
Disease control Recruiting nowThis study tests how well people with well-controlled recurrent pericarditis (a condition where the heart's lining swells repeatedly) can switch from their current treatments to a new drug called KPL-387 taken alone. About 80 adults will be enrolled to find the best dosing plan a…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for heart inflammation sufferers: KPL-387 trial launches
Disease control Recruiting nowThis study tests whether a new drug called KPL-387 can safely and effectively treat recurrent pericarditis, a condition where the lining around the heart becomes inflamed again and again. About 165 adults who still have symptoms despite standard treatments will take part. The goa…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug aims to tame recurring heart lining pain
Disease control Recruiting nowThis study tests an experimental drug called VTX2735 in 50 adults who have repeated episodes of pericarditis (inflammation of the lining around the heart). The goal is to see if the drug is safe and can reduce pain and inflammation. Participants receive different doses over sever…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE2 • Sponsor: Zomagen Biosciences Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New pill may keep heart inflammation away without lifelong drugs
Disease control Recruiting nowThis study tests whether CardiolRx can prevent pericarditis (inflammation around the heart) from coming back. About 110 adults who have been stable on an IL-1 blocker for at least a year will stop that drug and start CardiolRx or a placebo. The goal is to see if more people stay …
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC